# Humacyte, Inc.: Form 8-K, filed Aug 12, 2026

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2026-08-12
- Accepted by EDGAR: Aug 12, 2026, 07:03 ET
- Period: 2026-08-12
- Accession: 0001104659-26-094440
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465926094440/tm2622949d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465926094440/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465926094440/tm2622949d1_8k.htm

Filed Aug 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-094440. Last ingested by Listed: Nov 11, 2026, 01:52 ET. No prices; not investment advice.